References
- Annamalai P, Thayman M, Rajan S, Raman LS, Ramasubbu S, Perumal P. 2015. Ethyl acetate extract from marine sponge Hyattella cribriformis exhibit potent anticancer activity by promoting tubulin polymerization as evidenced mitotic arrest and induction of apoptosis. Pharmacogn Mag. 11(42):345–355.
- Beedessee G, Ramanjooloo A, Aubert G, Eloy L, Surnam-Boodhun R, van Soest RWM, Cresteil T, Marie D. 2012. Cytotoxic activities of hexane, ethyl acetate and butanol extracts of marine sponges from Mauritian Waters on human cancer cell lines. Environ Toxicol Pharm. 34(2):397–408.
- Collin R, Diaz MC, Norenburg J, Rocha RM, Sanchez JA, Schulze A, Schwartz M, Valdes A. 2005. Photographic identification guide to some common marine invertebrates of Bocas Del Toro, Panama. Caribb J Sci. 41(3):638–707.
- Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. 2019. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 144(8):1941–1953.
- Hechtel GJ. 1965. A systematic study of the Demospongiae of Port Royal, Jamaica. New Haven (CT): Yale University Peabody Museum of Natural History. (Bulletin; 20).
- Hirata Y, Uemura D. 1986. Halichondrins antitumor polyether macrolides from a marine sponge. Pure Appl Chem. 58(5):701–710.
- Hüsemann L, Reese A, Radine C, Piekorz RP, Budach W, Sohn D, Jänicke RU. 2020. The microtubule targeting agents eribulin and paclitaxel activate similar signaling pathways and induce cell death predominantly in a caspase-independent manner. Cell Cycle. 19(4):464–478.
- Khalifa SAM, Elias N, Farag MA, Chen L, Saeed A, Hegazy M, Moustafa MS, El-Wahed AA, Al-Mousawi SM, Musharraf SG, Chang FR, et al. 2019. Marine natural products: a source of novel anticancer drugs. Mar Drugs. 17(9):491–521.
- Nagelkerken I, Blaber SJM, Bouillon S, Green P, Haywood M, Kirton LG, Meynecke JO, Pawlik J, Penrose HM, Sasekumar A, et al. 2008. The habitat function of mangroves for terrestrial and marine fauna: a review. Aquat Bot. 89(2):155–185.
- Nandy A, Gangopadhyay S, Mukhopadhyay A. 2014. Individualizing breast cancer treatment - the dawn of personalized medicine. Exp Cell Res. 320(1):1–11.
- Newman DJ, Cragg GM. 2016. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 79(3):629–661.
- Pawlik JR. 1998. Coral reef sponges: do predatory fishes affect their distribution? Limnol Oceanogr. 43(6):1396–1399.
- Rützler K, van Soest RWM, Piantoni C. 2009. Sponges (Porifera) of the Gulf of Mexico. In: Felder DL, Camp DK, editors. Gulf of Mexico origin, waters, and biota. 1st ed. Vol. 1. Biodiversity. College Station (TX): Texas A&M University Press; p. 285–313.
- Suffness M, Pezzuto JM. 1991. Assays related to cancer drug discovery. In: Hostettmann K, editor. Methods in plant biochemistry: assays for bioactivity. London (UK): Academic Press; p. 71–133.
- Vonthron-Sénécheau C, Bernard-Weniger B, Ouattara M, Tra-Bi F, Kamenan A, Lobstein A, Brun R, Anton R. 2003. In vitro antiplasmodial activity and cytotoxicity of ethnobotanically selected Ivorian plants. J Ethnopharmacol. 87(2–3):221–225.
- Wang H, Vo T, Hajar A, Li S, Chen X, Parissenti AM, Brindley DN, Wang Z. 2014. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells. BMC Cancer. 14(1):37.
- Wulff JL. 2005. Trade-offs in resistance to competitors and predators, and their effects on the diversity of tropical marine sponges. J Anim Ecol. 74(2):313–321.